Joseph C. Glorioso, PhD

Ex-Officio | Editor-in-Chief, Molecular Therapy

Joseph C Glorioso, PhD is the former Chair and currently Distinguished Professor of the Dept of Microbiology and Molecular Genetics at the University of Pittsburgh School of Medicine, Pittsburgh, PA. He has engaged in fundamental studies of the pathogenesis and immunology of herpes simplex virus (HSV) and is a world-wide leader in the development of HSV gene vectors applied to the treatment of human disease using gene therapy strategies.

He is a founding board member of the American Society for Gene and Cell Therapy and former president of the ASGCT, founding editor of the Nature Journal Gene therapy, former president of the National Association of Microbiology and Immunology Medical School Chairs, Former Chair of the American Association for Cancer Gene Therapy, former member of the NIH RAC Committee for review of gene therapy protocols and a former member of the HIN National Gene Vector Laboratory.

He is a recipient of the Gene Therapy Pioneer Award from the journal of Human Gene Therapy, Paradigm Builder Lectureship from the International Society of Neurovirology and the 2021 ASM Award for Applied and Biotechnological Research. He is a Fellow of the American Society for Microbiology, the American Association of the Advancement of Science and the National Academy of Inventors.